ODTX filings
Corporate insider profile
Jeffrey M Leiden Filing Activity
Latest reported as Director of Odyssey Therapeutics, Inc. (ODTX).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $100,000
- Latest transaction
- May 8, 2026
Affiliated corporations
Reported company relationships
Transaction history
